Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,780.00
-80.00 (-1.65%)
At close: Mar 26, 2025, 3:30 PM KST
-11.32%
Market Cap 78.47B
Revenue (ttm) 190.44B
Net Income (ttm) -5.36B
Shares Out 15.33M
EPS (ttm) -357.00
PE Ratio n/a
Forward PE n/a
Dividend 75.00 (1.57%)
Ex-Dividend Date Dec 27, 2024
Volume 622,894
Average Volume 3,619,727
Open 4,870.00
Previous Close 4,860.00
Day's Range 4,750.00 - 5,000.00
52-Week Range 3,070.00 - 6,130.00
Beta 0.69
RSI 58.06
Earnings Date n/a

About Korea Arlico Pharm

Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases. Korea Arlico Pharm Co.,Ltd. w... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 112
Stock Exchange KOSDAQ
Ticker Symbol 260660
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.